Ricardo C. Berrios

Ricardo C. Berrios

Auto-generated profile, based on publicly available information

Ricardo C. Berrios

Adhera Health Inc, 101 Cooper St, Santa Cruz, CA, United States, 1 8313455357

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
AJAlba Jiménez-Díaz
Alba Jiménez-Díaz
MPMaitena Pierantonelli
Maitena Pierantonelli
PCPatricia Morte Coscolín
Patricia Morte Coscolín
ASAmaia Salinas-Uhalte
Amaia Salinas-Uhalte
SPSilvia Quer Palomas
Silvia Quer Palomas
AAAntonio de Arriba-Muñoz
Antonio de Arriba-Muñoz
Background: Caregivers of children with growth hormone deficiency often face emotional challenges (eg, stress) associated with their children’s health conditions. This psychological burden might affect children’s adherence to treatment and hinder their health-related quality of life (HrQoL). This assumption is leading to seriously considering multidimensional clinical approaches to pediatric health conditions where the emotional well-being of caregivers should be accounted for to optimize children’s health outcomes. Novel mobile health (mHealth) solutions based on emotional and behavioral change techniques can play a promising role because they are increasingly used within different health areas to support adaptive psychological functioning. However, whether and how mHealth solutions of this type of emotional well-being support caregivers of children with growth-related problems is an issue that needs to be clarified. Objective: This study aimed to gather qualitative information to better understand individualized experiences of caregiving of children undergoing growth hormone therapy (GHt) and perceived barriers or facilitators for the adoption of an mHealth solution called Adhera Caring Digital Program (ACDP). Methods: A total of 10 family caregivers were recruited at Miguel Servet Children’s Hospital, and they engaged with the ACDP for 1 month. The ACDP is a mobile-based digital intervention focused on promoting the overall well-being of family caregivers which provides access to personalized education, motivational mobile-based messages, and mental well-being exercises such as mindfulness or respiratory exercises. Subsequently, an individual semistructured interview was performed to gather qualitative user experience information. Results: The digital intervention was well-received. The ACDP was found to be useful, easy to use, and understandable, addressing all the difficulties expressed by caregivers. It was also noted to be particularly helpful at the beginning of the treatment and, for some families, became a natural tool that strengthened the parent-child relationship. Conclusions: The ACDP is a promising and well-accepted tool that enhances the experience of patients and caregivers. It improves the management of growth hormone deficiency and promotes the overall well-being of family caregivers. Trial Registration: ClinicalTrials NCT04812665; https://clinicaltrials.gov/study/NCT04812665 International Registered Report Identifier (IRRID): RR2-10.1186/s12911-022-01935-1

8 April 2025
Verified
Book Chapter
Open access
PDF file
ACAna Rocio Conde
Ana Rocio Conde
SPSilvia Quer Palomas
Silvia Quer Palomas
RBRicardo C. Berrios
Ricardo C. Berrios
LLLuis Luque
Luis Luque
RSRafael Subirán
Rafael Subirán
MMMaría José Moreno-Jiménez
María José Moreno-Jiménez
Family caregivers of individuals with schizophrenia face significant physical, emotional, and financial challenges, often sacrificing self-care and careers, particularly in low-middle-income families. Despite the benefits of family interventions, barriers like stigma and limited access persist. Mobile health (mHealth) offers a promising alternative by providing tailored psychosocial support, though long-term engagement is challenging. This study aims to understand caregiver’s needs to develop a user-centered digital intervention. Participatory workshops with caregivers, individuals with schizophrenia, and healthcare professionals revealed key issues, including the need for evidence-based education and emotional support. Caregivers reported confusion, loneliness, and stress, especially in the initial stages. The proposed digital solution, which integrates educational content and self-care activities, was well-received. Participants valued educational units on understanding schizophrenia and improving communication with the person receiving care and healthcare providers. They suggested including education on legal aspects and economic aid for families, along with connections to local activities and support groups.

9 July 2025 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
AAAntonio de Arriba-Muñoz
Antonio de Arriba-Muñoz
EMElisa Civitani Monzón
Elisa Civitani Monzón
MFMaria Pilar Ferrer
Maria Pilar Ferrer
MFMarta Ferrer-Lozano
Marta Ferrer-Lozano
SPSilvia Quer Palomas
Silvia Quer Palomas
LLLuis Luque
Luis Luque
Background: Caregivers of children living with type 1 diabetes (T1D) face multiple challenges that significantly impact their mental health and quality of life. The well-being of caregivers directly affects the management of the child’s condition. The Adhera Caring Digital Program (ACDP) is a comprehensive, digitally delivered program, designed to support family caregivers in enhancing self-management and well-being. This study aims to assess how the ACDP influences caregivers’ mood, emotional well-being, and health-related quality of life within the context of T1D. Objective: This study aimed to evaluate the impact of ACDP on caregivers’ psychological well-being and caregiving outcomes. Methods: This was a two-step, prospective, mixed methods study targeting caregivers of children living with T1D who were under the care of a pediatric endocrinologist at Miguel Servet Children’s University Hospital in Zaragoza, Spain. In substudy 1 (SS1), qualitative and quantitative data were collected to optimize the ACDP. In substudy 2 (SS2), caregivers used the optimized ACDP for three months. Psychometric assessments were conducted at baseline and follow-up to evaluate positive mood states, general well-being, self-efficacy, and lifestyle behaviors. This paper focuses on SS2. Results: Ninety caregivers participated in SS2. Positive affect significantly increased (P<.001), and negative affect decreased (P<.001) on the Positive and Negative Affect Schedule (PANAS). Depression, anxiety, and stress scores were reduced (P<.001) on the Depression, Anxiety and Stress Scale-21 Items (DASS-21). General well-being, measured by the Mental Health Continuum-Short Form (MHC-SF) and self-efficacy, assessed using General Self-Efficacy Scale (GSE), improved significantly (P<.001). Health-related quality of life (HrQoL) scores and Mediterranean Diet Quality Index scores increased modestly (P=.03, and P=.04, respectively). Conclusions: The ACDP intervention improved caregivers’ psychological well-being and self-efficacy. These findings highlight the potential of digital solutions to support caregiver mental health and positively influence diabetes management. Future research should explore long-term outcomes and scalability.

27 October 2025 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
AAAntonio de Arriba-Muñoz
Antonio de Arriba-Muñoz
AGAmalia M García-Durán
Amalia M García-Durán
PSPatricia Sanz-Aznar
Patricia Sanz-Aznar
SPSilvia Quer Palomas
Silvia Quer Palomas
IBIoannis Bilionis
Ioannis Bilionis
LLLuis Luque
Luis Luque
Background: Managing a child undergoing growth hormone treatment (GHt) can be burdensome for the families, which can lead to psychological problems and poor treatment adherence. The Adhera Caring Digital Program (ACDP) is a mobile-based digital health intervention designed to support the physical and mental well-being of families of individuals with chronic conditions. Objective: This study aimed to evaluate the clinical feasibility of a digital intervention to support families by focusing on caregivers of children undergoing GHt and its impact on treatment adherence. Methods: This is a prospective observational study. A total of 51 caregivers of children undergoing GHt with low adherence (below 85%) to treatment were recruited at the Pediatric Endocrinology Unit at the Miguel Servet Children’s University Hospital and enrolled into the ACDP for 3 months. Results: A total of 51 parents participated in the digital intervention for 3 months. The use of ACDP was associated with a significant increase in adherence rate ( P <.001). At baseline, all families had suboptimal adherence (below 85%), and after the intervention, 75% (n=38) of the families reached optimal levels of adherence. Also, the perceived pain of injection was reduced, as well as anxiety and stress. Initially, 21.56% (n=11) of caregivers reported depression symptoms, categorized as mild (11.76%, n=6), moderate (7.84%, n=4), and extremely severe (1.96%, n=1), while post intervention, only 1.96% (n=1) of caregivers reported depression as “severe.” Anxiety levels at baseline were reported by a total of 23.53% (n=12) of caregivers (mild: 7.84%, n=4, moderate: 13.73%, n=7, and severe: 1.96%, n=1). After the intervention, only 11.76% (n=6) reported mild (5.88%, n=3) or moderate (5.88%, n=3) anxiety levels. Initially, 23.5% (n=12) of caregivers reported stress as mild (7.84%, n=4), moderate (13.72%, n=7), and severe (1.96%, n=1) stress, and following the intervention, these symptoms reduced to 7.84% (n=4) (mild: 5.88%, n=3, severe: 1.96%, n=1). Conclusions: The ACDP is a promising tool, and it has been demonstrated to significantly increase the adherence rate, adding value to the patient and caregiver journey, and improving the management of growth hormone deficiency while promoting the overall well-being of family caregivers. Our results show that the digital support provided by the solution significantly increased the quality of life of the caregivers by increasing their psychological, emotional, and social well-being and decreasing their depression, anxiety, and stress symptoms.

25 April 2025 in JMIR Preprints
Verified
Preprint
Open access
AJAlba Jiménez-Díaz
Alba Jiménez-Díaz
MPMaitena Pierantonelli
Maitena Pierantonelli
PCPatricia Morte Coscolín
Patricia Morte Coscolín
ASAmaia Salinas-Uhalte
Amaia Salinas-Uhalte
SPSilvia Quer Palomas
Silvia Quer Palomas
AAAntonio de Arriba-Muñoz
Antonio de Arriba-Muñoz
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

30 November 2023 in JMIR Preprints
Verified
Preprint
Open access
AJAlba Jiménez-Díaz
Alba Jiménez-Díaz
MPMaitena Pierantonelli
Maitena Pierantonelli
PCPatricia Morte Coscolín
Patricia Morte Coscolín
ASAmaia Salinas-Uhalte
Amaia Salinas-Uhalte
SPSilvia Quer Palomas
Silvia Quer Palomas
AAAntonio de Arriba-Muñoz
Antonio de Arriba-Muñoz
BACKGROUND Caregivers of children with growth hormone deficiency often face emotional challenges (eg, stress) associated with their children’s health conditions. This psychological burden might affect children’s adherence to treatment and hinder their health-related quality of life (HrQoL). This assumption is leading to seriously considering multidimensional clinical approaches to pediatric health conditions where the emotional well-being of caregivers should be accounted for to optimize children’s health outcomes. Novel mobile health (mHealth) solutions based on emotional and behavioral change techniques can play a promising role because they are increasingly used within different health areas to support adaptive psychological functioning. However, whether and how mHealth solutions of this type of emotional well-being support caregivers of children with growth-related problems is an issue that needs to be clarified. OBJECTIVE This study aimed to gather qualitative information to better understand individualized experiences of caregiving of children undergoing growth hormone therapy (GHt) and perceived barriers or facilitators for the adoption of an mHealth solution called Adhera Caring Digital Program (ACDP). METHODS A total of 10 family caregivers were recruited at Miguel Servet Children’s Hospital, and they engaged with the ACDP for 1 month. The ACDP is a mobile-based digital intervention focused on promoting the overall well-being of family caregivers which provides access to personalized education, motivational mobile-based messages, and mental well-being exercises such as mindfulness or respiratory exercises. Subsequently, an individual semistructured interview was performed to gather qualitative user experience information. RESULTS The digital intervention was well-received. The ACDP was found to be useful, easy to use, and understandable, addressing all the difficulties expressed by caregivers. It was also noted to be particularly helpful at the beginning of the treatment and, for some families, became a natural tool that strengthened the parent-child relationship. CONCLUSIONS The ACDP is a promising and well-accepted tool that enhances the experience of patients and caregivers. It improves the management of growth hormone deficiency and promotes the overall well-being of family caregivers. CLINICALTRIAL ClinicalTrials NCT04812665; https://clinicaltrials.gov/study/NCT04812665 INTERNATIONAL REGISTERED REPORT RR2-10.1186/s12911-022-01935-1